9 WEEK PLACEBO CONTROLLED, DOUBLE BLIND, RANDOMIZED PARALLEL STUDY OF MODAFINIL

这项研究检查了一种实验性药物莫达非尼在 嗜睡症的治疗 这项研究大约在 美国26个景点 有嗜睡症病史的受试者为 筛查以假设没有其他重大医疗问题和药物- 自由状态。 然后，他们被带到CRC和睡眠实验室， 夜间睡眠研究和白天测试，以确认诊断 嗜睡症和建立基线功能水平。 科目 在为期9周的双盲安慰剂对照实验中 莫达非尼，200 mg或400 mg。睡眠和白天的随访研究 在协议期间的另外两个时间执行功能。

This study examins the effects of an experimental drug, Modafinil, in the treatment of Narcolepsy. The study is being carried out in approximately 26 sites around the US. Subjects with a history of Narcolepsy are screened to assume absense of other significant medical problems and drug- free status. They are then brought into the CRC and sleep lab for overnight sleep studies and daytime tests to confirm the diagnosis of Narcolepsy and to establish the level of baseline functioning. Subjects are then treated in a nine week, double-blind, placebo-controlled paradigm with Modafinil, 200mg or 400mg. Follow up studies of sleep and daytime funcioning are carried out at two other times during the protocol.